Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Identifying Off-Label Prescriptions Through Data Mining in Danish Community Pharmacy Servers: An Exploratory Study on Desmopressin, Diclofenac, Fucidin, Mirtazapine and Quetiapine.

Andrulyte M, Bjerrum OJ.

Basic Clin Pharmacol Toxicol. 2018 Aug;123(2):155-160. doi: 10.1111/bcpt.13009. Epub 2018 Apr 25.

PMID:
29575543
2.

The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004-2015.

Gjerden P, Bramness JG, Tvete IF, Slørdal L.

Eur J Clin Pharmacol. 2017 Sep;73(9):1173-1179. doi: 10.1007/s00228-017-2281-8. Epub 2017 Jun 16.

PMID:
28623386
3.

Off-label Use of Quetiapine in Medical Inpatients and Postdischarge.

Lee TC, Desforges P, Murray J, Saleh RR, McDonald EG.

JAMA Intern Med. 2016 Sep 1;176(9):1390-1. doi: 10.1001/jamainternmed.2016.3309. No abstract available.

PMID:
27400391
4.

Changing Pattern of Sedative Use in Older Adults: A Population-Based Cohort Study.

Iaboni A, Bronskill SE, Reynolds KB, Wang X, Rochon PA, Herrmann N, J Flint A.

Drugs Aging. 2016 Jul;33(7):523-33. doi: 10.1007/s40266-016-0380-3.

PMID:
27241038
5.

Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.

Litten RZ, Wilford BB, Falk DE, Ryan ML, Fertig JB.

Subst Abus. 2016 Apr-Jun;37(2):286-98. doi: 10.1080/08897077.2015.1133472. Review.

PMID:
26928397
6.

Quetiapine safety in older adults: a systematic literature review.

El-Saifi N, Moyle W, Jones C, Tuffaha H.

J Clin Pharm Ther. 2016 Feb;41(1):7-18. doi: 10.1111/jcpt.12357. Review.

PMID:
26813985
7.

Misuse and Associated Harms of Quetiapine and Other Atypical Antipsychotics.

Montebello ME, Brett J.

Curr Top Behav Neurosci. 2017;34:125-139. doi: 10.1007/7854_2015_424.

PMID:
26695164
8.

Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends.

Carton L, Cottencin O, Lapeyre-Mestre M, Geoffroy PA, Favre J, Simon N, Bordet R, Rolland B.

Curr Pharm Des. 2015;21(23):3280-97. Review.

PMID:
26088115
9.

Antipsychotics as antidepressants.

Roberts RJ, Lohano KK, El-Mallakh RS.

Asia Pac Psychiatry. 2016 Sep;8(3):179-88. doi: 10.1111/appy.12186. Epub 2015 May 12. Review.

PMID:
25963405
10.

[Hyperkinetic disorders in childhood and adolescence- an analysis of KinderAGATE 2009-2012].

Stegmann B, Rexroth CA, Wenzel-Seifert K, Haen E.

Z Kinder Jugendpsychiatr Psychother. 2015 Mar;43(2):101-14. German.

PMID:
25951625
11.

Indications of atypical antipsychotics in the elderly.

McKean A, Monasterio E.

Expert Rev Clin Pharmacol. 2015 Jan;8(1):5-7. doi: 10.1586/17512433.2015.974557. Epub 2014 Oct 29.

PMID:
25354148
12.

Prevalence of atypical antipsychotic use in psychiatric outpatients: comparison of women of childbearing age with men.

Camsarı U, Viguera AC, Ralston L, Baldessarini RJ, Cohen LS.

Arch Womens Ment Health. 2014 Dec;17(6):583-6. doi: 10.1007/s00737-014-0465-0. Epub 2014 Sep 25.

PMID:
25253022
13.

Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010.

Okumura Y, Togo T, Fujita J.

Int Psychogeriatr. 2015 Mar;27(3):407-15. doi: 10.1017/S1041610214001975. Epub 2014 Sep 12. Erratum in: Int Psychogeriatr. 2015 Mar;27(3):417-8.

PMID:
25213318
14.

Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications.

Burcu M, Zito JM, Ibe A, Safer DJ.

J Child Adolesc Psychopharmacol. 2014 Apr;24(3):112-9. doi: 10.1089/cap.2013.0094. Epub 2014 Apr 1.

PMID:
24690011
15.

Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.

Citrome L, Kalsekar I, Guo Z, Laubmeier K, Hebden T.

Clin Ther. 2013 Dec;35(12):1867-75. doi: 10.1016/j.clinthera.2013.09.006. Epub 2013 Oct 8.

16.

Efficacy of quetiapine off-label uses: data synthesis.

Carney AC.

J Psychosoc Nurs Ment Health Serv. 2013 Aug;51(8):11-8. doi: 10.3928/02793695-20130709-01. Epub 2013 Jul 18. Review.

PMID:
23848159
17.

[No quetiapine for sleeping disorders].

Tak LM, van Berlo-van de Laar IR, Doornbos B.

Ned Tijdschr Geneeskd. 2013;157(4):A5740. Dutch.

PMID:
23343742
18.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
19.

Quetiapine use: science or clever marketing?

Monasterio E, McKean A.

Aust N Z J Psychiatry. 2013 Jan;47(1):96-7. doi: 10.1177/0004867412455234. Epub 2012 Jul 16. No abstract available.

PMID:
22802551
20.

Off-label use of atypical antipsychotics: cause for concern?

McKean A, Monasterio E.

CNS Drugs. 2012 May 1;26(5):383-90. doi: 10.2165/11632030-000000000-00000.

PMID:
22448598

Supplemental Content

Loading ...
Support Center